Adlai Nortye (ANL) Competitors $1.77 +0.05 (+2.91%) Closing price 03:59 PM EasternExtended Trading$1.74 -0.02 (-1.41%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ANL vs. ALEC, LXEO, DBVT, VOR, PBYI, RNAC, JBIO, ALLO, FENC, and ENGNShould you be buying Adlai Nortye stock or one of its competitors? The main competitors of Adlai Nortye include Alector (ALEC), Lexeo Therapeutics (LXEO), DBV Technologies (DBVT), Vor Biopharma (VOR), Puma Biotechnology (PBYI), Cartesian Therapeutics (RNAC), Jade Biosciences (JBIO), Allogene Therapeutics (ALLO), Adherex Technologies (FENC), and enGene (ENGN). These companies are all part of the "pharmaceutical products" industry. Adlai Nortye vs. Its Competitors Alector Lexeo Therapeutics DBV Technologies Vor Biopharma Puma Biotechnology Cartesian Therapeutics Jade Biosciences Allogene Therapeutics Adherex Technologies enGene Adlai Nortye (NASDAQ:ANL) and Alector (NASDAQ:ALEC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations. Do institutionals & insiders hold more shares of ANL or ALEC? 35.2% of Adlai Nortye shares are owned by institutional investors. Comparatively, 85.8% of Alector shares are owned by institutional investors. 9.7% of Alector shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media refer more to ANL or ALEC? In the previous week, Alector had 7 more articles in the media than Adlai Nortye. MarketBeat recorded 10 mentions for Alector and 3 mentions for Adlai Nortye. Adlai Nortye's average media sentiment score of 1.46 beat Alector's score of 1.20 indicating that Adlai Nortye is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adlai Nortye 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alector 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, ANL or ALEC? Adlai Nortye has higher earnings, but lower revenue than Alector. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdlai Nortye$5M13.06-$51.87MN/AN/AAlector$100.56M2.86-$119.05M-$1.16-2.45 Do analysts recommend ANL or ALEC? Adlai Nortye currently has a consensus price target of $9.00, suggesting a potential upside of 408.47%. Alector has a consensus price target of $4.17, suggesting a potential upside of 46.71%. Given Adlai Nortye's higher probable upside, equities research analysts clearly believe Adlai Nortye is more favorable than Alector.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adlai Nortye 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Alector 2 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.29 Which has more risk & volatility, ANL or ALEC? Adlai Nortye has a beta of -0.94, suggesting that its stock price is 194% less volatile than the S&P 500. Comparatively, Alector has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Is ANL or ALEC more profitable? Adlai Nortye has a net margin of 0.00% compared to Alector's net margin of -142.10%. Adlai Nortye's return on equity of 0.00% beat Alector's return on equity.Company Net Margins Return on Equity Return on Assets Adlai NortyeN/A N/A N/A Alector -142.10%-112.06%-26.37% SummaryAdlai Nortye and Alector tied by winning 7 of the 14 factors compared between the two stocks. Get Adlai Nortye News Delivered to You Automatically Sign up to receive the latest news and ratings for ANL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANL vs. The Competition Export to ExcelMetricAdlai NortyeMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$63.47M$3.18B$5.83B$10.07BDividend YieldN/A2.26%5.25%4.53%P/E RatioN/A21.3175.5726.01Price / Sales13.06453.06536.77117.75Price / CashN/A45.8737.4259.95Price / Book2.579.6011.536.20Net Income-$51.87M-$53.33M$3.29B$270.65M7 Day Performance-0.56%0.61%0.44%2.77%1 Month Performance12.38%11.11%10.84%8.83%1 Year Performance-19.55%12.61%61.62%27.49% Adlai Nortye Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANLAdlai Nortye1.45 of 5 stars$1.77+2.9%$9.00+408.5%-20.4%$63.47M$5M0.00127Positive NewsGap DownALECAlector3.9021 of 5 stars$2.59+10.2%$4.17+60.9%-46.9%$262.13M$100.56M-2.23270Positive NewsHigh Trading VolumeLXEOLexeo Therapeutics2.533 of 5 stars$4.79flat$15.33+220.1%-52.0%$258.66M$650K-1.4758Positive NewsDBVTDBV Technologies2.8223 of 5 stars$9.44-2.2%$14.75+56.3%+141.0%$258.51M$4.15M-1.9880News CoverageGap DownVORVor Biopharma2.0777 of 5 stars$2.04+3.6%$6.07+197.4%+84.4%$258.43MN/A-1.24140Insider TradePBYIPuma Biotechnology4.0021 of 5 stars$5.11+1.4%$7.00+37.0%+103.0%$257.39M$230.50M5.21200RNACCartesian Therapeutics2.4444 of 5 stars$9.84-2.1%$40.00+306.5%-23.1%$255.84M$38.91M-0.1964Positive NewsJBIOJade Biosciences2.7307 of 5 stars$7.62-3.5%$16.00+110.0%N/A$248.62MN/A-0.2520ALLOAllogene Therapeutics2.6024 of 5 stars$1.12-0.9%$8.44+654.0%-54.0%$248.51M$20K-1.01310FENCAdherex Technologies1.5155 of 5 stars$8.91+0.5%$13.33+49.6%+75.6%$247.79M$47.54M-21.2110ENGNenGene2.6873 of 5 stars$4.80+3.9%$23.29+385.1%-15.7%$245.28MN/A-2.9131Trending NewsAnalyst ForecastGap Up Related Companies and Tools Related Companies Alector Alternatives Lexeo Therapeutics Alternatives DBV Technologies Alternatives Vor Biopharma Alternatives Puma Biotechnology Alternatives Cartesian Therapeutics Alternatives Jade Biosciences Alternatives Allogene Therapeutics Alternatives Adherex Technologies Alternatives enGene Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANL) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adlai Nortye Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Adlai Nortye With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANL Stock Alerts